GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (BOM:500488) » Definitions » E10

Abbott India (BOM:500488) E10 : ₹327.60 (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Abbott India E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Abbott India's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹135.090. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹327.60 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Abbott India's average E10 Growth Rate was 20.40% per year. During the past 3 years, the average E10 Growth Rate was 15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Abbott India was 15.70% per year. The lowest was 7.80% per year. And the median was 11.75% per year.

As of today (2024-06-07), Abbott India's current stock price is ₹26991.55. Abbott India's E10 for the quarter that ended in Mar. 2024 was ₹327.60. Abbott India's Shiller PE Ratio of today is 82.39.

During the past 13 years, the highest Shiller PE Ratio of Abbott India was 103.49. The lowest was 66.37. And the median was 78.98.


Abbott India E10 Historical Data

The historical data trend for Abbott India's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India E10 Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 217.43 211.44 225.44 272.16 327.60

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 272.16 287.95 302.36 317.43 327.60

Competitive Comparison of Abbott India's E10

For the Drug Manufacturers - General subindustry, Abbott India's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Abbott India's Shiller PE Ratio falls into.



Abbott India E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Abbott India's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=135.09/153.0345*153.0345
=135.090

Current CPI (Mar. 2024) = 153.0345.

Abbott India Quarterly Data

per share eps CPI Adj_EPS
201406 23.970 94.103 38.981
201409 30.000 96.780 47.438
201412 30.370 96.780 48.023
201503 23.420 97.163 36.887
201506 31.560 99.841 48.375
201509 28.660 101.753 43.104
201512 31.780 102.901 47.263
201603 27.760 102.518 41.439
201606 34.830 105.961 50.303
201609 35.300 105.961 50.982
201612 40.260 105.196 58.568
201703 19.790 105.196 28.790
201706 22.710 107.109 32.448
201709 64.720 109.021 90.848
201712 54.300 109.404 75.955
201803 47.100 109.786 65.654
201806 38.780 111.317 53.314
201809 64.790 115.142 86.112
201812 55.080 115.142 73.207
201903 53.280 118.202 68.981
201906 55.030 120.880 69.668
201909 83.920 123.175 104.263
201912 87.850 126.235 106.500
202003 52.240 124.705 64.107
202006 84.870 127.000 102.268
202009 85.050 130.118 100.029
202012 83.360 130.889 97.464
202103 71.760 131.771 83.340
202106 92.120 134.084 105.139
202109 90.510 135.847 101.961
202112 93.740 138.161 103.832
202203 99.490 138.822 109.676
202206 96.770 142.347 104.035
202209 124.950 144.661 132.182
202212 116.160 145.763 121.955
202303 108.900 146.865 113.475
202306 136.580 150.280 139.083
202309 147.270 151.492 148.770
202312 146.340 152.924 146.445
202403 135.090 153.035 135.090

Add all the adjusted EPS together and divide 10 will get our e10.


Abbott India  (BOM:500488) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Abbott India's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=26991.55/327.6
=82.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Abbott India was 103.49. The lowest was 66.37. And the median was 78.98.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Abbott India E10 Related Terms

Thank you for viewing the detailed overview of Abbott India's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (BOM:500488) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (BOM:500488) Headlines

No Headlines